Lu-Ping Li1, Jing Lu, Tammy Franklin, Ying Zhou, Richard Solomon, Pottumarthi V Prasad. 1. From the *Department of Radiology/Center for Advanced Imaging, †Pritzker School of Medicine, University of Chicago, Chicago, IL; ‡Department of Obstetrics and Gynaecology, §Center for Biomedical and Research Informatics, NorthShore University HealthSystem, Evanston, IL; and ∥Department of Nephrology, University of Vermont, Burlington, VT.
Abstract
OBJECTIVES: The objective of this study was to assess whether streptozotocin (STZ)-induced diabetic rats develop iodinated contrast-induced acute kidney injury. The intrarenal R2* (=1/T2*) was evaluated continuously before, during, and after contrast administration. Renal injury was confirmed using urinary neutrophil gelatinase-associated lipocalin measurements. MATERIALS AND METHODS: Six Sprague-Dawley rats were administered with STZ to induce diabetes (group 1). R2* was measured before, during, and after administration of iodixanol. R2* readings were sampled from 4 renal regions: inner medulla, inner stripe of outer medulla (ISOM), outer stripe of outer medulla, and cortex. Peak R2* and initial upslope of R2* increase after iodinated contrast were calculated. Data from 12 nondiabetic rats pretreated with nitric oxide synthase and prostaglandin inhibitors to induce susceptibility to contrast-induced acute kidney injury (pretreatment model) from a previous study were reanalyzed for peak R2* and initial upslope of R2* increase after contrast. Six of these animals received saline (group 2), and the other 6 received furosemide (group 3) before iodixanol. RESULTS: Peak R2* and initial upslope of R2* increase were used as blood-oxygenation-level-dependent response parameters. R2* in ISOM was comparable in all 3 groups before administration of furosemide/saline. Except for the furosemide group, ISOM showed a rapid increase in R2* immediately after contrast administration. Unlike the L-NAME- and indomethacin-treated groups, the diabetic group showed a quick reversal of R2* toward baseline measurements after contrast administration. Urinary neutrophil gelatinase-associated lipocalin indicated significant increase in diabetic rats 4 hours after contrast administration. The observed trends with peak R2* and initial upslope of R2* increase in renal ISOM were in agreement with those of urinary neutrophil gelatinase-associated lipocalin. CONCLUSIONS: The STZ-induced diabetic rat may be suitable for studying the effects of iodinated contrast on renal oxygenation status and may mimic human condition closer than the pretreatment model described before. The peak R2* value and initial upslope of R2* in ISOM appear to be effective magnetic resonance imaging markers to predict renal injury after administration of an iodinated contrast agent.
OBJECTIVES: The objective of this study was to assess whether streptozotocin (STZ)-induced diabeticrats develop iodinated contrast-induced acute kidney injury. The intrarenal R2* (=1/T2*) was evaluated continuously before, during, and after contrast administration. Renal injury was confirmed using urinary neutrophil gelatinase-associated lipocalin measurements. MATERIALS AND METHODS: Six Sprague-Dawley rats were administered with STZ to induce diabetes (group 1). R2* was measured before, during, and after administration of iodixanol. R2* readings were sampled from 4 renal regions: inner medulla, inner stripe of outer medulla (ISOM), outer stripe of outer medulla, and cortex. Peak R2* and initial upslope of R2* increase after iodinated contrast were calculated. Data from 12 nondiabetic rats pretreated with nitric oxide synthase and prostaglandin inhibitors to induce susceptibility to contrast-induced acute kidney injury (pretreatment model) from a previous study were reanalyzed for peak R2* and initial upslope of R2* increase after contrast. Six of these animals received saline (group 2), and the other 6 received furosemide (group 3) before iodixanol. RESULTS: Peak R2* and initial upslope of R2* increase were used as blood-oxygenation-level-dependent response parameters. R2* in ISOM was comparable in all 3 groups before administration of furosemide/saline. Except for the furosemide group, ISOM showed a rapid increase in R2* immediately after contrast administration. Unlike the L-NAME- and indomethacin-treated groups, the diabetic group showed a quick reversal of R2* toward baseline measurements after contrast administration. Urinary neutrophil gelatinase-associated lipocalin indicated significant increase in diabeticrats 4 hours after contrast administration. The observed trends with peak R2* and initial upslope of R2* increase in renal ISOM were in agreement with those of urinary neutrophil gelatinase-associated lipocalin. CONCLUSIONS: The STZ-induced diabeticrat may be suitable for studying the effects of iodinated contrast on renal oxygenation status and may mimic human condition closer than the pretreatment model described before. The peak R2* value and initial upslope of R2* in ISOM appear to be effective magnetic resonance imaging markers to predict renal injury after administration of an iodinated contrast agent.
Authors: Lu-Ping Li; Anthony T Vu; Belinda S Y Li; Eugene Dunkle; Pottumarthi V Prasad Journal: J Magn Reson Imaging Date: 2004-11 Impact factor: 4.813
Authors: Kathleen E De Greef; Dirk K Ysebaert; Veerle Persy; Sven R Vercauteren; Marc E De Broe Journal: Kidney Int Date: 2003-05 Impact factor: 10.612
Authors: T Niendorf; A Pohlmann; K Arakelyan; B Flemming; K Cantow; J Hentschel; D Grosenick; M Ladwig; H Reimann; S Klix; S Waiczies; E Seeliger Journal: Acta Physiol (Oxf) Date: 2014-09-30 Impact factor: 6.311
Authors: Yongfang Wang; Xin Zhang; Bin Wang; Yang Xie; Yi Wang; Xuan Jiang; Rongjia Wang; Ke Ren Journal: Korean J Radiol Date: 2019-05 Impact factor: 3.500